Search Results - "Harjai, Kishore"

Drug-eluting stents in patients with chronic kidney disease: a prospective registry study by Shenoy, Chetan, Boura, Judy, Orshaw, Pamela, Harjai, Kishore J

“…Chronic kidney disease (CKD) is strongly associated with adverse outcomes after percutaneous coronary intervention (PCI). There are limited data on the…”
Get full text

A Comparison of Contemporary Definitions of Contrast Nephropathy in Patients Undergoing Percutaneous Coronary Intervention and a Proposal for a Novel Nephropathy Grading System by Harjai, Kishore J., MD, Raizada, Amol, MD, Shenoy, Chetan, MD, Sattur, Sudhakar, MD, Orshaw, Pamela, RN, Yaeger, Karl, BS, Boura, Judy, MS, Aboufares, Ali, MD, Sporn, Daniel, MD, Stapleton, Dwight, MD

“…Contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) has multiple definitions. We attempted to identify the optimal definition of…”
Get full text

The Blueprint for Successful Device Development: Disruptive Innovation and Co-Opetition, Then Randomized Trials by Harjai, Kishore J., Blankenship, James C.

“…•Novel devices must meet rigorous thresholds for clinical efficacy and safety. Some innovations succeed more than others.•Variations in the success trajectory…”
Get full text

Efficiency, Safety, and Quality of Life After Transcatheter Aortic Valve Implantation Performed With Moderate Sedation Versus General Anesthesia by Harjai, Kishore J., Bules, Thomas, Berger, Andrea, Young, Bonnie, Singh, Deepak, Carter, Russell, Agarwal, Shikhar, Crockett, Samuel, Mascarenhas, Vernon, Nawaz, Yassir, Stella, Joseph, Burnside, Joyce, Skelding, Kimberly A., Desciak, Matthew, Casale, Alfred S.

“…There is growing interest in “minimalist” transcatheter aortic valve implantation (M-TAVI), performed with conscious sedation instead of general anesthesia…”
Get full text

Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification by Bartholomew, Beth A, Harjai, Kishore J, Dukkipati, Srinivas, Boura, Judith A, Yerkey, Michael W, Glazier, Susan, Grines, Cindy L, O'Neill, William W

“…Radiocontrast-induced nephropathy (RCIN) after percutaneous coronary intervention (PCI) is associated with grave consequences, but risk stratification of…”
Get full text

Elevated Cardiac Troponin Is Most Often Associated With Type 2 Myocardial Infarction in Trauma Patients by Culhane, John T, Drogan, Jillian, Okeke, Raymond I, Harjai, Kishore

“…Introduction Cardiac troponin (cTn) forms an essential part of the diagnostic criteria for myocardial infarction (MI). Type 1 MI is a primary coronary arterial…”
Get full text

Early Readmissions After Percutaneous Coronary Intervention in a Rural Tertiary Care Center (from the Guthrie Health Off-Label Stent [GHOST] Registry) by Harjai, Kishore J., MD, MMM, Singh, Maninder, MD, Boura, Judy, MS

“…Early readmissions (ERs) impose a huge cost to the health care system, lower patients' quality of life, and may be an indicator of quality of initial care. We…”
Get full text

2016 Revision of the SCAI position statement on public reporting by Klein, Lloyd W., Harjai, Kishore J., Resnic, Fred, Weintraub, William S., Vernon Anderson, H., Yeh, Robert W., Feldman, Dmitriy N., Gigliotti, Osvaldo S., Rosenfeld, Kenneth, Duffy, Peter

Get full text

Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement by Paradis, Jean‐Michel, White, Jonathon M., Généreux, Philippe, Urena, Marina, Doshi, Darshan, Nazif, Tamim, Hahn, Rebecca, George, Isaac, Khalique, Omar, Harjai, Kishore, Lasalle, Laura, Labbé, Benoit M., DeLarochellière, Robert, Doyle, Daniel, Dumont, Éric, Mohammadi, Siamak, Leon, Martin B., Rodés‐Cabau, Josep, Kodali, Susheel

“…Background The influence of coronary artery disease (CAD) on clinical and echocardiographic outcomes after transcatheter aortic valve replacement (TAVR) is…”
Get full text

Clinical Outcomes in Patients With the Concomitant Use of Clopidogrel and Proton Pump Inhibitors After Percutaneous Coronary Intervention: An Analysis From the Guthrie Health Off-Label Stent (GHOST) Investigators by Harjai, Kishore J, Shenoy, Chetan, Orshaw, Pam, Usmani, Samer, Boura, Judy, Mehta, Rajendra H

“…BACKGROUND—The concomitant use of proton pump inhibitors (PPIs) with clopidogrel is suspected to be associated with an adverse impact on clinical outcomes in…”
Get full text

TRANSCATHETER AORTIC VALVE REPLACEMENT PATIENTS WITH ATRIAL FIBRILLATION ARE AT HIGH RISK FOR STROKE AND BLEEDING: A RATIONALE FOR CONSIDERATION OF TRANSCATHETER AORTIC VALVE REPLACEMENT AND LEFT ATRIAL APPENDAGE CLOSURE AS COMPLEMENTARY THERAPIES by Harjai, Kishore J, Hopkins, Eugenia, Mascarenhas, Vernon, Crockett, Samuel, Singh, Deepak, Stahl, Russell, Bules, Thomas J, Scalzo, Lori, Vijayaraman, Pugazhendhi

“…Background: Patients who undergo transcatheter aortic valve replacement (TAVR) and have atrial fibrillation (AF) are at high risk of stroke, major bleeding and…”
Get full text

Longitudinal necrotic shafts near TCFAs—A potential novel mechanism for plaque rupture to trigger ACS? by Brezinski, Mark E, Harjai, Kishore J

“…Abstract It has been questioned for over 15 years why only less than 20% of TCFAs trigger ACS.  We illustrate TCFA rupture into adjacent longitudinal necrotic…”
Get full text

Transcatheter Aortic Valve Replacement: Game-Changing Innovation for Patients with Aortic Stenosis by Harjai, Kishore J, Paradis, Jean-Michel, Kodali, Susheel

“…Transcatheter aortic valve replacement (TAVR) is an emerging technology for the management of patients with severe aortic stenosis (AS). First reported in…”
Get full text

Percutaneous Coronary Intervention: 2015 in Review by Grines, Cindy L, Harjai, Kishore J, Schreiber, Theodore L

“…In order to keep the interventional community up-to-date with the overwhelming amount of new data, we have selected where we believe to be the most important…”
Get more information

Coronary and Structural Heart Disease Interventions During COVID-19 Pandemic: A Road Map for Clinicians and Health Care Delivery Systems by Harjai, Kishore J., Agarwal, Shikhar, Bauch, Terry, Bernardi, Mark, Casale, Alfred S., Green, Sandy, Harostock, Michael, Ierovante, Nicholas, Mascarenhas, Vernon, Matsumura, Martin, Nawaz, Yassir, Scott, Thomas, Singh, Deepak, Stella, Joseph J., Vijayaraman, Pugazhendi, Yost, Gregory, Blankenship, James C.

“…Because of the COVID-19 pandemic, cath labs have had to modify their workflow for elective and urgent patients. We surveyed 16 physicians across 3 hospitals in…”
Get full text

Transcatheter aortic valve replacement: The year in review 2016 by Harjai, Kishore J, Grines, Cindy L, Paradis, Jean-Michael, Kodali, Susheel

“…Transcatheter aortic valve replacement (TAVR) continued to make major strides in 2016, simultaneously expanding its application to lower risk patients as well…”
Get more information

Transcatheter Aortic Valve Replacement: 2015 in Review by Harjai, Kishore J, Grines, Cindy L, Leon, Martin B

“…Transcatheter aortic valve replacement (TAVR) has emerged as an attractive option for patients with severe symptomatic aortic stenosis (AS) who are either at…”
Get more information

Transcatheter aortic valve replacement: The year in review 2017 by Thakur, Kamia, Nazif, Tamim M, Khalique, Omar K, Paradis, Jean-Michel, Harjai, Kishore J

“…This article is a continuation of our previously published annual reviews of transcatheter aortic valve replacement (TAVR). In 2017, TAVR further established a…”
Get more information

Clinical and angiographic correlates and outcomes of suboptimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention by MEHTA, Rajendra H, HARJAI, Kishore J, COX, David, STONE, Gregg W, BRODIE, Bruce, BOURA, Judy, O'NEILL, William, GRINES, Cindy L

Get full text

Thrombocytopenia following percutaneous coronary intervention by Shenoy, Chetan, Harjai, Kishore J

“…Thrombocytopenia following percutaneous coronary intervention (PCI) is an underappreciated condition that is often clinically challenging. There are no…”
Get more information